{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T23:59:06Z","timestamp":1774483146165,"version":"3.50.1"},"reference-count":80,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T00:00:00Z","timestamp":1673395200000},"content-version":"vor","delay-in-days":1928,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["li.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Laboratory Investigation"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1038\/labinvest.2017.100","type":"journal-article","created":{"date-parts":[[2017,9,4]],"date-time":"2017-09-04T08:41:04Z","timestamp":1504514464000},"page":"1167-1179","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"title":["Stem cell therapies for myocardial infarction in clinical trials: bioengineering and biomaterial aspects"],"prefix":"10.1016","volume":"97","author":[{"given":"Akon","family":"Higuchi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nien-Ju","family":"Ku","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yeh-Chia","family":"Tseng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chih-Hsien","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hsing-Fen","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S Suresh","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing-Dong","family":"Ling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yung","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdullah A","family":"Alarfaj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Murugan A","family":"Munusamy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Benelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kadarkarai","family":"Murugan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1038\/labinvest.2017.100_bib1","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/nrd4738","article-title":"Current status of pluripotent stem cells: moving the first therapies to the clinic","volume":"14","author":"Kimbrel","year":"2015","journal-title":"Nat Rev Drug Discov"},{"key":"10.1038\/labinvest.2017.100_bib2","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.1242\/dev.092270","article-title":"Stem cells in retinal regeneration: past, present and future","volume":"140","author":"Ramsden","year":"2013","journal-title":"Development"},{"key":"10.1038\/labinvest.2017.100_bib3","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1089\/jop.2015.0153","article-title":"Pluripotent stem cell-based therapies in combination with substrate for the treatment of age-related macular degeneration","volume":"32","author":"Pennington","year":"2016","journal-title":"J Ocul Pharmacol Ther"},{"key":"10.1038\/labinvest.2017.100_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.preteyeres.2015.06.004","article-title":"Stem cell based therapies for age-related macular degeneration: the promises and the challenges","volume":"48","author":"Nazari","year":"2015","journal-title":"Prog Retin Eye Res"},{"key":"10.1038\/labinvest.2017.100_bib5","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.tins.2013.03.006","article-title":"Development of human embryonic stem cell therapies for age-related macular degeneration","volume":"36","author":"Carr","year":"2013","journal-title":"Trends Neurosci"},{"key":"10.1038\/labinvest.2017.100_bib6","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1093\/bmb\/ldr018","article-title":"Cardiac cell therapy: where we've been, where we are, and where we should be headed","volume":"98","author":"Malliaras","year":"2011","journal-title":"Br Med Bull"},{"key":"10.1038\/labinvest.2017.100_bib7","first-page":"e2","article-title":"Heart disease and stroke statistics\u20142012 update: a report from the American Heart Association","volume":"125","author":"Roger","year":"2012","journal-title":"Circulation"},{"key":"10.1038\/labinvest.2017.100_bib8","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1056\/NEJMoa013474","article-title":"Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction","volume":"346","author":"Moss","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1038\/labinvest.2017.100_bib9","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/labinvest.2014.132","article-title":"Generation of pluripotent stem cells without the use of genetic material","volume":"95","author":"Higuchi","year":"2015","journal-title":"Lab Invest"},{"key":"10.1038\/labinvest.2017.100_bib10","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1016\/j.progpolymsci.2014.01.002","article-title":"Design of polymeric materials for culturing human pluripotent stem cells: progress toward feeder-free and xeno-free culturing","volume":"39","author":"Higuchi","year":"2014","journal-title":"Prog Polym Sci"},{"key":"10.1038\/labinvest.2017.100_bib11","doi-asserted-by":"crossref","first-page":"3297","DOI":"10.1021\/cr300426x","article-title":"Physical cues of biomaterials guide stem cell differentiation fate","volume":"113","author":"Higuchi","year":"2013","journal-title":"Chem Rev"},{"key":"10.1038\/labinvest.2017.100_bib12","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/S0140-6736(12)60028-2","article-title":"Embryonic stem cell trials for macular degeneration: a preliminary report","volume":"379","author":"Schwartz","year":"2012","journal-title":"Lancet"},{"key":"10.1038\/labinvest.2017.100_bib13","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S0140-6736(14)61376-3","article-title":"Human embryonic stem cell-derived retinal pigment epithelium in patients with age-related macular degeneration and Stargardt's macular dystrophy: follow-up of two open-label phase 1\/2 studies","volume":"385","author":"Schwartz","year":"2015","journal-title":"Lancet"},{"key":"10.1038\/labinvest.2017.100_bib14","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.stemcr.2013.12.007","article-title":"Characterization of human induced pluripotent stem cell-derived retinal pigment epithelium cell sheets aiming for clinical application","volume":"2","author":"Kamao","year":"2014","journal-title":"Stem Cell Rep"},{"key":"10.1038\/labinvest.2017.100_bib15","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1093\/eurheartj\/ehu192","article-title":"Towards a clinical use of human embryonic stem cell-derived cardiac progenitors: a translational experience","volume":"36","author":"Menasche","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1038\/labinvest.2017.100_bib16","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1093\/eurheartj\/ehv189","article-title":"Human embryonic stem cell-derived cardiac progenitors for severe heart failure treatment: first clinical case report","volume":"36","author":"Menasche","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1038\/labinvest.2017.100_bib17","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1016\/j.healun.2014.10.008","article-title":"Long-term functional benefits of human embryonic stem cell-derived cardiac progenitors embedded into a fibrin scaffold","volume":"34","author":"Bellamy","year":"2015","journal-title":"J Heart Lung Transplant"},{"key":"10.1038\/labinvest.2017.100_bib18","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1002\/stem.580","article-title":"A fibrin patch-based enhanced delivery of human embryonic stem cell-derived vascular cell transplantation in a porcine model of postinfarction left ventricular remodeling","volume":"29","author":"Xiong","year":"2011","journal-title":"Stem Cells"},{"key":"10.1038\/labinvest.2017.100_bib19","doi-asserted-by":"crossref","first-page":"248","DOI":"10.5966\/sctm.2011-0028","article-title":"Embryonic stem cell-based cardiopatches improve cardiac function in infarcted rats","volume":"1","author":"Vallee","year":"2012","journal-title":"Stem Cells Transl Med"},{"key":"10.1038\/labinvest.2017.100_bib20","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1161\/CIRCRESAHA.113.300216","article-title":"Patching the heart: cardiac repair from within and outside","volume":"113","author":"Ye","year":"2013","journal-title":"Circ Res"},{"key":"10.1038\/labinvest.2017.100_bib21","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s10554-010-9714-0","article-title":"Assessment of acute myocardial infarction: current status and recommendations from the North American society for Cardiovascular Imaging and the European Society of Cardiac Radiology","volume":"27","author":"Stillman","year":"2011","journal-title":"Int J Cardiovasc Imaging"},{"key":"10.1038\/labinvest.2017.100_bib22","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/35070587","article-title":"Bone marrow cells regenerate infarcted myocardium","volume":"410","author":"Orlic","year":"2001","journal-title":"Nature"},{"key":"10.1038\/labinvest.2017.100_bib23","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1080\/14017430510009131","article-title":"Autologous stem cell transplantation in acute myocardial infarction: The ASTAMI randomized controlled trial. Intracoronary transplantation of autologous mononuclear bone marrow cells, study design and safety aspects","volume":"39","author":"Lunde","year":"2005","journal-title":"Scand Cardiovasc J"},{"key":"10.1038\/labinvest.2017.100_bib24","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0140-6736(04)16626-9","article-title":"Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial","volume":"364","author":"Wollert","year":"2004","journal-title":"Lancet"},{"key":"10.1038\/labinvest.2017.100_bib25","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1161\/CIRCULATIONAHA.105.575118","article-title":"Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months' follow-up data from the randomized, controlled BOOST (BOne marrOw transfer to enhance ST-elevation infarct regeneration) trial","volume":"113","author":"Meyer","year":"2006","journal-title":"Circulation"},{"key":"10.1038\/labinvest.2017.100_bib26","doi-asserted-by":"crossref","first-page":"2978","DOI":"10.1093\/eurheartj\/ehp374","article-title":"Intracoronary bone marrow cell transfer after myocardial infarction: 5-year follow-up from the randomized-controlled BOOST trial","volume":"30","author":"Meyer","year":"2009","journal-title":"Eur Heart J"},{"key":"10.1038\/labinvest.2017.100_bib27","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1056\/NEJMoa060186","article-title":"Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction","volume":"355","author":"Schachinger","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1038\/labinvest.2017.100_bib28","doi-asserted-by":"crossref","first-page":"2775","DOI":"10.1093\/eurheartj\/ehl388","article-title":"Improved clinical outcome after intracoronary administration of bone-marrow-derived progenitor cells in acute myocardial infarction: final 1-year results of the REPAIR-AMI trial","volume":"27","author":"Schachinger","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1038\/labinvest.2017.100_bib29","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1161\/CIRCULATIONAHA.106.671545","volume":"116","author":"Erbs","year":"2007","journal-title":"Circulation"},{"key":"10.1038\/labinvest.2017.100_bib30","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.ahj.2008.11.011","volume":"157","author":"Dill","year":"2009","journal-title":"Am Heart J"},{"key":"10.1038\/labinvest.2017.100_bib31","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1161\/CIRCHEARTFAILURE.108.843243","article-title":"Clinical outcome 2 years after intracoronary administration of bone marrow-derived progenitor cells in acute myocardial infarction","volume":"3","author":"Assmus","year":"2010","journal-title":"Circ Heart Fail"},{"key":"10.1038\/labinvest.2017.100_bib32","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0140-6736(05)67861-0","article-title":"Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial","volume":"367","author":"Janssens","year":"2006","journal-title":"Lancet"},{"key":"10.1038\/labinvest.2017.100_bib33","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1093\/eurheartj\/ehp073","volume":"30","author":"Tendera","year":"2009","journal-title":"Eur Heart J"},{"key":"10.1038\/labinvest.2017.100_bib34","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.ahj.2010.11.024","volume":"161","author":"Trachtenberg","year":"2011","journal-title":"Am Heart J"},{"key":"10.1038\/labinvest.2017.100_bib35","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1016\/j.jacc.2009.06.055","article-title":"A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction","volume":"54","author":"Hare","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1038\/labinvest.2017.100_bib36","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1016\/S0140-6736(11)61590-0","article-title":"Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial","volume":"378","author":"Bolli","year":"2011","journal-title":"Lancet"},{"key":"10.1038\/labinvest.2017.100_bib37","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1001\/jama.2012.28726","article-title":"Effect of the use and timing of bone marrow mononuclear cell delivery on left ventricular function after acute myocardial infarction: the TIME randomized trial","volume":"308","author":"Traverse","year":"2012","journal-title":"JAMA"},{"key":"10.1038\/labinvest.2017.100_bib38","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1001\/jama.2011.1670","article-title":"Effect of intracoronary delivery of autologous bone marrow mononuclear cells 2 to 3 weeks following acute myocardial infarction on left ventricular function: the LateTIME randomized trial","volume":"306","author":"Traverse","year":"2011","journal-title":"JAMA"},{"key":"10.1038\/labinvest.2017.100_bib39","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1093\/eurheartj\/ehq449","volume":"32","author":"Hirsch","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1038\/labinvest.2017.100_bib40","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1093\/eurheartj\/ehq455","article-title":"Intracoronary autologous mononucleated bone marrow cell infusion for acute myocardial infarction: results of the randomized multicenter BONAMI trial","volume":"32","author":"Roncalli","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1038\/labinvest.2017.100_bib41","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/S0140-6736(12)60195-0","article-title":"Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): a prospective, randomised phase 1 trial","volume":"379","author":"Makkar","year":"2012","journal-title":"Lancet"},{"key":"10.1038\/labinvest.2017.100_bib42","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1016\/j.jacc.2013.02.071","article-title":"Cardiopoietic stem cell therapy in heart failure: the C-CURE (Cardiopoietic stem Cell therapy in heart failURE) multicenter randomized trial with lineage-specified biologics","volume":"61","author":"Bartunek","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1038\/labinvest.2017.100_bib43","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/s00392-013-0595-9","volume":"102","author":"Wohrle","year":"2013","journal-title":"Clin Res Cardiol"},{"key":"10.1038\/labinvest.2017.100_bib44","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.ijcard.2015.02.084","article-title":"Safety and efficacy of intracoronary hypoxia-preconditioned bone marrow mononuclear cell administration for acute myocardial infarction patients: The CHINA-AMI randomized controlled trial","volume":"184","author":"Hu","year":"2015","journal-title":"Int J Cardiol"},{"key":"10.1038\/labinvest.2017.100_bib45","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1093\/eurheartj\/ehv493","article-title":"A randomized double-blind control study of early intra-coronary autologous bone marrow cell infusion in acute myocardial infarction: the REGENERATE-AMI clinical trialdagger","volume":"37","author":"Choudry","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1038\/labinvest.2017.100_bib46","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1056\/NEJMoa055706","article-title":"Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction","volume":"355","author":"Lunde","year":"2006","journal-title":"N Eng J Med"},{"key":"10.1038\/labinvest.2017.100_bib47","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3346\/jkms.2014.29.1.23","article-title":"A randomized, open-label, multicenter trial for the safety and efficacy of adult mesenchymal stem cells after acute myocardial infarction","volume":"29","author":"Lee","year":"2014","journal-title":"J Korean Med Sci"},{"key":"10.1038\/labinvest.2017.100_bib48","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1186\/s12916-015-0399-z","article-title":"Intracoronary infusion of Wharton's jelly-derived mesenchymal stem cells in acute myocardial infarction: double-blind, randomized controlled trial","volume":"13","author":"Gao","year":"2015","journal-title":"BMC Med"},{"key":"10.1038\/labinvest.2017.100_bib49","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1159\/000187652","article-title":"Cell therapy of acute myocardial infarction: open questions","volume":"113","author":"Dimmeler","year":"2009","journal-title":"Cardiology"},{"key":"10.1038\/labinvest.2017.100_bib50","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1093\/eurheartj\/ehi817","article-title":"Impact of intracoronary bone marrow cell transfer on diastolic function in patients after acute myocardial infarction: results from the BOOST trial","volume":"27","author":"Schaefer","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1038\/labinvest.2017.100_bib51","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1093\/eurjhf\/hfr148","article-title":"Short- and long-term outcomes of intracoronary and endogenously mobilized bone marrow stem cells in the treatment of ST-segment elevation myocardial infarction: a meta-analysis of randomized control trials","volume":"14","author":"Zimmet","year":"2012","journal-title":"Eur J Heart Fail"},{"key":"10.1038\/labinvest.2017.100_bib52","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/j.yjmcc.2008.03.007","article-title":"Bones of contention: marrow-derived cells in myocardial regeneration","volume":"44","author":"Sussman","year":"2008","journal-title":"J Mol Cell Cardiol"},{"key":"10.1038\/labinvest.2017.100_bib53","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.ijcard.2014.11.005","article-title":"Effectiveness and safety of selected bone marrow stem cells on left ventricular function in patients with acute myocardial infarction: a meta-analysis of randomized controlled trials","volume":"177","author":"Liu","year":"2014","journal-title":"Int J Cardiol"},{"key":"10.1038\/labinvest.2017.100_bib54","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1016\/j.jacc.2006.07.044","volume":"48","author":"Engelmann","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1038\/labinvest.2017.100_bib55","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1161\/CIRCULATIONAHA.105.610469","volume":"113","author":"Ripa","year":"2006","journal-title":"Circulation"},{"key":"10.1038\/labinvest.2017.100_bib56","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1002\/clc.20575","article-title":"Impact of timing on efficacy and safetyof intracoronary autologous bone marrow stem cells transplantation in acute myocardial infarction: a pooled subgroup analysis of randomized controlled trials","volume":"32","author":"Zhang","year":"2009","journal-title":"Clin Cardiol"},{"key":"10.1038\/labinvest.2017.100_bib57","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1093\/eurheartj\/ehn456","article-title":"Bone marrow cells are a rich source of growth factors and cytokines: implications for cell therapy trials after myocardial infarction","volume":"29","author":"Korf-Klingebiel","year":"2008","journal-title":"Eur Heart J"},{"key":"10.1038\/labinvest.2017.100_bib58","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1161\/CIRCINTERVENTIONS.113.001009","article-title":"Intracoronary stem cell infusion after acute myocardial infarction: a meta-analysis and update on clinical trials","volume":"7","author":"de Jong","year":"2014","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1038\/labinvest.2017.100_bib59","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1161\/01.RES.0000150856.47324.5b","article-title":"Cells expressing early cardiac markers reside in the bone marrow and are mobilized into the peripheral blood after myocardial infarction","volume":"95","author":"Kucia","year":"2004","journal-title":"Circ Res"},{"key":"10.1038\/labinvest.2017.100_bib60","doi-asserted-by":"crossref","first-page":"10217","DOI":"10.1038\/srep10217","article-title":"A hybrid-membrane migration method to isolate high-purity adipose-derived stem cells from fat tissues","volume":"5","author":"Higuchi","year":"2015","journal-title":"Sci Rep"},{"key":"10.1038\/labinvest.2017.100_bib61","doi-asserted-by":"crossref","first-page":"4278","DOI":"10.1016\/j.biomaterials.2014.02.004","article-title":"Purification of human adipose-derived stem cells from fat tissues using PLGA\/silk screen hybrid membranes","volume":"35","author":"Chen","year":"2014","journal-title":"Biomaterials"},{"key":"10.1038\/labinvest.2017.100_bib62","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.cardfail.2017.03.002","article-title":"C-Kit positive cardiac stem cells and bone marrow-derived mesenchymal stem cells synergistically enhance angiogenesis and improve cardiac function after myocardial infarction in a paracrine manner","volume":"23","author":"Bao","year":"2017","journal-title":"J Card Fail"},{"key":"10.1038\/labinvest.2017.100_bib63","doi-asserted-by":"crossref","first-page":"e96725","DOI":"10.1371\/journal.pone.0096725","article-title":"c-kit+ Cardiac stem cells alleviate post-myocardial infarction left ventricular dysfunction despite poor engraftment and negligible retention in the recipient heart","volume":"9","author":"Hong","year":"2014","journal-title":"PLoS One"},{"key":"10.1038\/labinvest.2017.100_bib64","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1634\/stemcells.2004-0013","article-title":"Mesenchymal stem cells in the Wharton's jelly of the human umbilical cord","volume":"22","author":"Wang","year":"2004","journal-title":"Stem Cells"},{"key":"10.1038\/labinvest.2017.100_bib65","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1634\/stemcells.2007-0439","article-title":"Wharton's jelly-derived cells are a primitive stromal cell population","volume":"26","author":"Troyer","year":"2008","journal-title":"Stem Cells"},{"key":"10.1038\/labinvest.2017.100_bib66","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.3727\/096368912X662444","article-title":"Common expression of stemness molecular markers and early cardiac transcription factors in human Wharton's jelly-derived mesenchymal stem cells and embryonic stem cells","volume":"22","author":"Gao","year":"2013","journal-title":"Cell Transplant"},{"key":"10.1038\/labinvest.2017.100_bib67","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1097\/MCA.0b013e3283640f00","article-title":"Wharton's jelly-derived mesenchymal stem cells promote myocardial regeneration and cardiac repair after miniswine acute myocardial infarction","volume":"24","author":"Zhang","year":"2013","journal-title":"Coron Artery Dis"},{"key":"10.1038\/labinvest.2017.100_bib68","doi-asserted-by":"crossref","first-page":"46","DOI":"10.2174\/1574888X11308010007","article-title":"Wharton's jelly or bone marrow mesenchymal stromal cells improve cardiac function following myocardial infarction for more than 32 weeks in a rat model: a preliminary report","volume":"8","author":"Lopez","year":"2013","journal-title":"Curr Stem Cell Res Therapy"},{"key":"10.1038\/labinvest.2017.100_bib69","doi-asserted-by":"crossref","first-page":"421","DOI":"10.2217\/rme.12.17","article-title":"Adipose-derived mesenchymal stromal cells for chronic myocardial ischemia (MyStromalCell Trial): study design","volume":"7","author":"Qayyum","year":"2012","journal-title":"Regen Med"},{"key":"10.1038\/labinvest.2017.100_bib70","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.actbio.2016.12.027","article-title":"Human placenta hydrogel reduces scarring in a rat model of cardiac ischemia and enhances cardiomyocyte and stem cell cultures","volume":"52","author":"Francis","year":"2017","journal-title":"Acta Biomater"},{"key":"10.1038\/labinvest.2017.100_bib71","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.actbio.2016.11.058","article-title":"Maturation of human embryonic stem cell-derived cardiomyocytes (hESC-CMs) in 3D collagen matrix: effects of niche cell supplementation and mechanical stimulation","volume":"49","author":"Zhang","year":"2017","journal-title":"Acta Biomater"},{"key":"10.1038\/labinvest.2017.100_bib72","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.actbio.2013.10.033","article-title":"Temporal impact of substrate mechanics on differentiation of human embryonic stem cells to cardiomyocytes","volume":"10","author":"Hazeltine","year":"2014","journal-title":"Acta Biomater"},{"key":"10.1038\/labinvest.2017.100_bib73","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.progpolymsci.2016.09.002","article-title":"Polymeric design of cell culture materials that guide the differentiation of human pluripotent stem cells","volume":"65","author":"Higuchi","year":"2017","journal-title":"Prog Polym Sci"},{"key":"10.1038\/labinvest.2017.100_bib74","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/labinvest.2016.37","article-title":"Human amniotic mesenchymal stem cells alleviate lung injury induced by ischemia and reperfusion after cardiopulmonary bypass in dogs","volume":"96","author":"Qiang","year":"2016","journal-title":"Lab Invest"},{"key":"10.1038\/labinvest.2017.100_bib75","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ijcard.2011.08.003","article-title":"TGFbeta1 contributes to cardiomyogenic-like differentiation of human bone marrow mesenchymal stem cells","volume":"163","author":"Mohanty","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1038\/labinvest.2017.100_bib76","doi-asserted-by":"crossref","first-page":"3816256","DOI":"10.1155\/2016\/3816256","article-title":"Differentiation of bone marrow mesenchymal stem cells to cardiomyocyte-like cells is regulated by the combined low dose treatment of transforming growth factor-beta1 and 5-azacytidine","volume":"2016","author":"Shi","year":"2016","journal-title":"Stem Cells Int"},{"key":"10.1038\/labinvest.2017.100_bib77","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1159\/000446869","article-title":"Caveolin-1 plays an important role in the differentiation of bone marrow-derived mesenchymal stem cells into cardiomyocytes","volume":"136","author":"Chen","year":"2017","journal-title":"Cardiology"},{"key":"10.1038\/labinvest.2017.100_bib78","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1515\/hsz-2016-0151","article-title":"Synergistic induction of cardiomyocyte differentiation from human bone marrow mesenchymal stem cells by interleukin 1beta and 5-azacytidine","volume":"397","author":"Khajeniazi","year":"2016","journal-title":"Biol Chem"},{"key":"10.1038\/labinvest.2017.100_bib79","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/nature06894","article-title":"Human cardiovascular progenitor cells develop from a KDR+ embryonic-stem-cell-derived population","volume":"453","author":"Yang","year":"2008","journal-title":"Nature"},{"key":"10.1038\/labinvest.2017.100_bib80","doi-asserted-by":"crossref","unstructured":"Higuchi A, Kumar SS, Benelli G et al. Stem cell therapies for reversing vision Los. Trends Biotechnolhttp:\/\/dx.doi.org\/10.1016\/j.tibtech.2017.06.016.","DOI":"10.1016\/j.tibtech.2017.06.016"}],"container-title":["Laboratory Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/labinvest2017100.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/labinvest2017100","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0023683722007334?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0023683722007334?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/labinvest.2017.100","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/www.nature.com\/articles\/labinvest2017100.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T19:31:28Z","timestamp":1758396688000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0023683722007334"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":80,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["S0023683722007334"],"URL":"https:\/\/doi.org\/10.1038\/labinvest.2017.100","relation":{},"ISSN":["0023-6837"],"issn-type":[{"value":"0023-6837","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Stem cell therapies for myocardial infarction in clinical trials: bioengineering and biomaterial aspects","name":"articletitle","label":"Article Title"},{"value":"Laboratory Investigation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/labinvest.2017.100","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 United States & Canadian Academy of Pathology.","name":"copyright","label":"Copyright"}]}}